[HTML][HTML] Longitudinal single-cell analysis of SARS-CoV-2–reactive B cells uncovers persistence of early-formed, antigen-specific clones

L Scharf, H Axelsson, A Emmanouilidi, NR Mathew… - JCI insight, 2023 - ncbi.nlm.nih.gov
Understanding persistence and evolution of B cell clones after COVID-19 infection and
vaccination is crucial for predicting responses against emerging viral variants and optimizing …

[HTML][HTML] Integrating artificial intelligence-based epitope prediction in a SARS-CoV-2 antibody discovery pipeline: caution is warranted

DD Acar, W Witkowski, M Wejda, R Wei, T Desmet… - …, 2024 - thelancet.com
Summary Background SARS-CoV-2-neutralizing antibodies (nABs) showed great promise
in the early phases of the COVID-19 pandemic. The emergence of resistant strains …

[HTML][HTML] Redefining serological diagnostics with immunoaffinity proteomics

J Walter, Z Eludin, AP Drabovich - Clinical Proteomics, 2023 - Springer
Serological diagnostics is generally defined as the detection of specific human
immunoglobulins developed against viral, bacterial, or parasitic diseases. Serological tests …

Application of germline antibody features to vaccine development, antibody discovery, antibody optimization and disease diagnosis

Y Zhang, Q Li, L Luo, C Duan, J Shen, Z Wang - Biotechnology Advances, 2023 - Elsevier
Although the efficacy and commercial success of vaccines and therapeutic antibodies have
been tremendous, designing and discovering new drug candidates remains a labor-, time …

[HTML][HTML] AbAgIntPre: A deep learning method for predicting antibody-antigen interactions based on sequence information

Y Huang, Z Zhang, Y Zhou - Frontiers in Immunology, 2022 - frontiersin.org
Introduction Antibody-mediated immunity is an essential part of the immune system in
vertebrates. The ability to specifically bind to antigens allows antibodies to be widely used in …

[HTML][HTML] Broadly neutralizing antibodies derived from the earliest COVID-19 convalescents protect mice from SARS-CoV-2 variants challenge

Q Liu, H Zhao, Z Li, Z Zhang, R Huang, M Gu… - … and Targeted Therapy, 2023 - nature.com
Abstract Coronavirus disease 2019 (COVID-19) was first reported three years ago, when a
group of individuals were infected with the original SARS-CoV-2 strain, based on which …

Evidence of antigenic drift in the fusion machinery core of SARS-CoV-2 spike

TJC Tan, AK Verma, A Odle, R Lei… - Proceedings of the …, 2024 - National Acad Sciences
Antigenic drift of SARS-CoV-2 is typically defined by mutations in the N-terminal domain and
receptor binding domain of spike protein. In contrast, whether antigenic drift occurs in the S2 …

On pre-trained language models for antibody

D Wang, F Ye, H Zhou - arXiv preprint arXiv:2301.12112, 2023 - arxiv.org
Antibodies are vital proteins offering robust protection for the human body from pathogens.
The development of general protein and antibody-specific pre-trained language models …

[HTML][HTML] Broadly neutralizing antibodies to SARS-CoV-2 provide novel insights into the neutralization of variants and other human coronaviruses

P Bajpai, V Singh, A Chandele… - Frontiers in Cellular and …, 2022 - frontiersin.org
Seven coronaviruses are known to cause infection/disease in humans. Of these, human
coronavirus (HCoV)-229E and HCoV-NL63 are alphacoronaviruses (α-CoVs), whereas …

[HTML][HTML] SARS-CoV-2 antibodies recognize 23 distinct epitopic sites on the receptor binding domain

J Jiang, CT Boughter, J Ahmad, K Natarajan… - Communications …, 2023 - nature.com
The COVID-19 pandemic and SARS-CoV-2 variants have dramatically illustrated the need
for a better understanding of antigen (epitope)-antibody (paratope) interactions. To gain …